Prospective Multicenter Study of the Relationship Between Virological Effectiveness and Compliance in HIV-1-infected Patients Treated With Bictegravir

RecruitingOBSERVATIONAL
Enrollment

120

Participants

Timeline

Start Date

February 11, 2025

Primary Completion Date

September 1, 2027

Study Completion Date

September 1, 2027

Conditions
HIV Antiretroviral Therapy (ART) Adherence
Interventions
DEVICE

Adherence measured by MEMS caps

The methodological choices made in this study are justified by the need to assess the effectiveness of bictegravir, taking into account the varying levels of adherence among PLHIV. The use of electronic antiretroviral caps (MEMS caps: https://aardexgroup.com/medication-event-monitoring-system/ ) and the intra-cellular TAF assay to measure drug concentrations will enable a combined, precise and objective assessment of treatment adherence, and constitute the originality of this research.

Trial Locations (8)

14000

RECRUITING

CHU de Caen, Caen

44000

NOT_YET_RECRUITING

CHU de Nantes, Nantes

45100

RECRUITING

CHU d'Orléans, Orléans

69000

NOT_YET_RECRUITING

Hôpitaux Civils de Lyon, Lyon

75013

NOT_YET_RECRUITING

CHU Pitié-Salpétrière, Paris

79000

NOT_YET_RECRUITING

CH de Niort, Niort

85000

NOT_YET_RECRUITING

CHD Vendée, La Roche-sur-Yon

86000

NOT_YET_RECRUITING

CHU de Poitiers, Poitiers

All Listed Sponsors
collaborator

Hôpital Côte de Nacre, CHU de Caen

UNKNOWN

lead

Association pour la promotion de la recherche en maladies infectieuses et tropicales dans le Loiret

OTHER